"Retina Consultants of Nevada was established in 1980 and we are proud to be the first eye care practice in Southern Nevada that focuses exclusively on retina disease diagnosis and treatment. Whether it is a simple treatment or a complicated surgery, our team is committed to helping you understand what is causing your vision problems and then fully explaining the treatment options. We understand that the interruption or loss of vision is very scary, so we work hard to provide a welcoming and comfortable environment for you."

During the past decade, Retina Consultants of Nevada conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Nevada" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Kodiak Sciences Inc" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Nevada" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Nevada" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (3 trials), "Retinal Vein Occlusion" (3 trials), "Macular Edema" (2 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Retina Consultants of Nevada" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Nevada" are "Drug" (14 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (3 trials), "Sham Procedure" (3 trials), "Faricimab" (2 trials), "KSI-301" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Nevada" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Nevada". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Retina Consultants of Nevada, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Nevada, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".